Here are four things to know:
1. The proposal would cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl by 7-15 percent, in 2019, according to
2. The proposed drug manufacturing cut coincides with President Donald Trump’s “Safe Prescribing Plan,” which seeks to reduce opioid prescription fills by one-third over the next three years.
3. This past March, President Trump also revealed a tougher antiopioid campaign to cut opioid prescriptions by adjusting federal programs to cut opioid prescriptions and boost funding. He also proposed the death penalty for dealers.
4. The DEA and Justice Department’s proposal comes on the heels of a CDC estimate, showing 48,612 Americans died from opioid overdoses in 2017.
More articles on opioids:
72K Americans died from drug overdoses in 2017, CDC estimates
80+ people overdose in a Connecticut park in 1 day
Physician- & organization-related initiatives effective at lowering opioid prescriptions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
